Description: 2003 Valuation Actuary Symposium, San Diego, CA. This session provided an overview of current statutory valuation issues pertaining to life and annuity products. Topics included: 1. Actuarial opinion and memorandum regulation amendments. 2. Progress on variable products reserving standards. 3. Regulation XXX mortality factors. 4. Adoption of the 2001 CSO. 5. Progress on the C-3 Phase II RBC project. 6. An update on annuity and life nonforfeiture.

Description: This session at the 2004 Valuation Actuary Symposium provides an overview of statutory valuation issues for life and annuity products including the Actuarial Opinion and Memorandum Regulation, variable products reserving standard, adoption of 2001 CSO, C-3 Phase II RBC project and nonforfeiture changes.

Description: 1996 Valuation Actuary Symposium. In this teaching session on liability modeling, the panelists discussed the key aspects of identifying and gathering the data required to construct models, the model building process including objectives and considerations, and the modeling process from the standpoint of policyholder and company behaviors.

Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 In this session the panelists discussed the issues related to the actuarial aspects associated with the demutualization process. The issues discussed included: • Developing historical and prospective assumptions • Aligning the models used in the company’s philosophy regarding dividend determination and pricing • Creating experience assumptions when less-than-perfect data exist • Determining who gets what • Complying with actuarial and accounting standards

Description: This session at the 1998 Valuation Actuary Symposium looks at mergers and acquisitions in the insurance business. Recent examples and actuarial considerations in M&A transactions are discussed.

Description: Panelists provide background and updates on a number of statutory issues relating to life and annuity products, including statutory codification implementation, Actuarial Guideline MMMM, Actuarial Guideline AXXX and implications of the movement to the 2001 CSO table. Changes to federal reporting requirements, through the Sarbanes-Oxley Act, are briefly discussed relative to the recent accounting problems in the news. From the 2002 Record of Society of Actuaries, Volume 28, No. 3. Session 78OF of the Boston Annual Meeting.

Description: From a session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Presents questions to actuaries who are experts in the field of actuarial valuation of insurance company assets and liabilities.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. In this open forum participants' questions were addressed by experts in the field. Some of the questions: 1. How does actuarial practice develop with regard to questions about interim results and asset-adequacy analysis projections? 2. If the present value measures used in typical asset-adequacy evaluation include a favorable adequacy opinion, are there patterns of interim results that under commonly accepted actuarial practice would require additional reserves to be established? 3. What is the most extreme stochastic modeling that you have seen? How many scenarios on how large a block, on how complex a model, on how many PCs or what type of computer that ran for over how many days? 4. Is codification retroactive? Does it impact any previous reserving methodologies put in place on policies issued before codification was effective? 5. What are your individual views on whether the federal government should provide a backstop to group or individual life insurance to handle terrorism catastrophes? 6. What are your thoughts are on the move toward stochastic methods for setting reserves?

Description: This session 33 OF of the 2004 Valuation Actuary Symposium is an opportunity for participants' questions to be addressed by the experts in the field. Questions may be raised by the participants from the floor and by the moderator and panelists as well.